COX6CP1

Across TCGA pan-cancer cohorts, COX6CP1 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of COX6CP1’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where COX6CP1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types COX6CP1 is over-expressed in tumor.

BRCA, READ, and STAD are the cancer types where COX6CP1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in COX6CP1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	All	All	+0.968	.002	4	view →
READ	Male	All	+0.693	.034	2	view →
STAD	All	II,III,IV	+0.494	.024	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

COX6CP1–BRCA

Open the BRCA breakdown →